This year's congress of the European Society for Medical Oncology featured some heavyweight data drops, with antibody-drug conjugates stealing much of the limelight. In addition to the standing ovation for Keytruda and Padcev’s bladder cancer results, here’s everything Fierce Pharma and Fierce Biotech covered during the conference. | 